Polynucleotide for treating systemic lupus erythematosus

Details Polynucleotide for treating systemic lupus erythematosus Polynucleotide for treating systemic lupus erythematosus

C - Chemistry, Metallurgy

07

H

C07H 21/00 (2006.01)

Patent

CA 2173878

Chemically defined conjugates or biologically stable polymers, such as copolymers of D-glutamic acid and D-lysine, and polynucleotide duplexes of at least 20 base pairs that have significant binding activity for human lupus anti-dsDNA autoantibodies. The duplexes are preferably homogeneous in length and structure and are bound to the polymer via reaction between an amino-reactive functional group located at or proximate a terminus of each duplex. These conjugates are tolerogens for human system lupus erythematosus.

Affiliated with

Also associated with

Rating

Polynucleotide for treating systemic lupus erythematosus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polynucleotide for treating systemic lupus erythematosus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotide for treating systemic lupus erythematosus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1798546